586 related articles for article (PubMed ID: 15256191)
1. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
2. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
Jozwiak S; Terczynski A
Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
[TBL] [Abstract][Full Text] [Related]
3. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
Kaminow L; Schimschock JR; Hammer AE; Vuong A
Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
[TBL] [Abstract][Full Text] [Related]
4. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
[TBL] [Abstract][Full Text] [Related]
5. [Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in adult patients with epilepsy resistant carbamazepine and valproate].
Jóźwiak S; Niedzielska K; Mańko E; Terczyński A
Neurol Neurochir Pol; 2000; 34(4):673-89. PubMed ID: 11105300
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
7. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.
Morris GL; Hammer AE; Kustra RP; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):509-12. PubMed ID: 15256187
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
Machado RA; García VF; Astencio AG; Cuartas VB
Seizure; 2013 Dec; 22(10):846-55. PubMed ID: 23916525
[TBL] [Abstract][Full Text] [Related]
11. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
Biton V; Mirza W; Montouris G; Vuong A; Hammer AE; Barrett PS
Neurology; 2001 Jan; 56(2):172-7. PubMed ID: 11160951
[TBL] [Abstract][Full Text] [Related]
12. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
Evans BK; Kustra RP; Hammer AE
Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
[TBL] [Abstract][Full Text] [Related]
13. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
Alvarez N; Besag F; Iivanainen M
J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
[TBL] [Abstract][Full Text] [Related]
14. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
15. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
[TBL] [Abstract][Full Text] [Related]
16. Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre.
Steinhoff BJ; Maren Staack A; Wisniewski I
Epileptic Disord; 2012 Dec; 14(4):379-87. PubMed ID: 23274162
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months.
Piña-Garza JE; Levisohn P; Gucuyener K; Mikati MA; Warnock CR; Conklin HS; Messenheimer J
Neurology; 2008 May; 70(22 Pt 2):2099-108. PubMed ID: 18077797
[TBL] [Abstract][Full Text] [Related]
18. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry.
Battino D; Tomson T; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Epilepsia; 2013 Sep; 54(9):1621-7. PubMed ID: 23848605
[TBL] [Abstract][Full Text] [Related]
19. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.
Saetre E; Perucca E; Isojärvi J; Gjerstad L;
Epilepsia; 2007 Jul; 48(7):1292-302. PubMed ID: 17561956
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine extended-release as adjunctive therapy for partial seizures.
Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
